Gene therapy isn’t on the horizon anymore; it’s here.  Precision medicine demands a level of personalization that few Specialty Pharmacies are equipped to handle.  PANTHERx®’s pure focus on rare and orphan conditions has propelled the company to the forefront of the industry for program personalization, making it the ideal partner to bring new gene therapies […]

PANTHERx® Specialty Pharmacy’s Fellowship program was featured in an article published by Specialty Pharmacy Continuum on April 11, 2018. The fellowship is designed to help address an emerging need in pharmacy – professionals with experience and specializations in both the business and clinical aspects of specialty pharmacy. During the fellowship, the fellows rotate through different […]

Following up on our win in the inaugural Specialty Pharmacy Patient Choice Award last year, PANTHERx® is excited to attend the second annual Patient Choice Awards taking place at Asembia 2018 Specialty Pharmacy Summit. “This is probably the best part of this Asembia meeting and, quite frankly, our entire year. Satisfaction is the ultimate measure […]

PANTHERx® Specialty Pharmacy is now stocking and dispensing Makena (hydroxyprogesterone caproate injection) subcutaneous auto-injector, a new drug-device combination product.  The new subcutaneous auto-injector offers a convenient, ready-to-use alternative to the intramuscular injection.  Makena is the only FDA approved treatment indicated to reduce the risk of preterm birth in women who are pregnant with one baby […]

Join the leaders from PANTHERx® Specialty Pharmacy at the 2018 sPCMA Business Forum, March 5-6, in Orlando, Florida.  The conference brings together leaders in specialty pharmacy, payers, PBMs, pharmaceutical manufacturers, and other stakeholders for collaboration, networking, and education. Leaders from PANTHERx® will be available for meetings outside of the scheduled agenda sessions.  David Stasiowski, Vice […]